Clinical Trial Update: Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating botulinum toxin injections to prevent paroxysmal atrial fibrillation. The study status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Paroxysmal Atrial Fibrillation | Phase 1 | Status: UNKNOWN